Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ALDH1A3-IN-1 (Compound 14) is a potent inhibitor of ALDH1A3 which can be used in prostate cancer research (IC50 = 0.63 μM; Ki = 0.46 μM) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | Inquiry |
Description | ALDH1A3-IN-1 (Compound 14) is a potent inhibitor of ALDH1A3 which can be used in prostate cancer research (IC50 = 0.63 μM; Ki = 0.46 μM) [1]. |
In vitro | ALDH1A3-IN-1 (Compound 14) exhibits significant antiproliferative effects on prostate cancer cell lines (PC3, LNCaP, and DU145) over a 96-hour treatment with concentrations ranging from 0-200 μM, displaying IC50 values of 47 ± 6, 25 ± 1, and 61 ± 5 μM, respectively [1]. Additionally, this compound effectively reduces the viability of primary prostate epithelial cells cultured from early-passage human tissue biopsies in a dose-dependent manner when administered at 50 and 200 μM for 72 hours, further demonstrating its potential therapeutic action against prostate cancer [1]. |
Molecular Weight | 284.19 |
Formula | C13H18BrNO |
CAS No. | 1695970-90-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ALDH1A3-IN-1 1695970-90-1 inhibitor inhibit